CEO is executing a massive pre-arranged selling plan, with over $220M in sales already completed in the past month. The 10b5-1 plan provides legal cover but the magnitude is unusual for a $39.6B company. Monitor for any acceleration of selling or additional Form 144 filings. The stock's OTC listing and mixed institutional sentiment (4 trims, 2 near-exits) add to the caution.
ONC drugs
ONC drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $359.27entry
- T+1 · 3mo ago −0.06%α −0.31% · $359.05
- T+5 · 3mo ago +2.75%α +3.15% · $369.15
- T+20 · 2mo ago −2.30%α −1.24% · $351.00
- T+60 · 13d ago +5.15%α +5.64% · $377.78
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Chairman and CEO John Oyler filed a Form 144 on August 10, 2026, signaling intent to sell approximately $83.9 million worth of BeOne Medicines (ONC) ADS shares. The filing covers shares acquired via vested stock options and founder shares, and is part of a pre-arranged 10b5-1 trading plan that has already generated over $220 million in sales since mid-July 2026. While the 10b5-1 plan provides some cover, the sheer scale of selling by the CEO is a notable signal.
Key Facts
- CEO John Oyler filed Form 144 to sell ADS shares valued at approximately $83.9 million.
- The filing covers 229,115 shares acquired from vested stock options (March 2025) and 11,695 founder shares (October 2014).
- Oyler has already sold ~$220 million in ONC ADS shares since July 10, 2026 under a 10b5-1 plan.
- Recent 10b5-1 sales include: $52.99M (Jul 16), $40.89M (Jul 14), $36.36M (Jul 15), $20.16M (Jul 17).
- The filing also includes sales from the Pan-Oyler Foundation, adding to total insider selling pressure.
- Market cap is $39.6B; the proposed sale represents ~0.2% of market cap, but cumulative recent sales exceed 0.5%.
- Institutional activity shows 4 trims and 2 near-exits among top holders in Q2 2026.
Financial Impact
Proposed sale of ~$83.9M in ADS shares by CEO; cumulative 10b5-1 sales since July 10 exceed $220M.
Risk Factors
- CEO selling at scale may signal lack of confidence in near-term valuation or fundamentals.
- Cumulative insider selling >0.5% of market cap in 30 days is elevated.
- OTC listing reduces liquidity and may amplify price impact of large sales.
- Institutional trimming and near-exits suggest some sophisticated holders are reducing exposure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-007895 |
| Document: 0001950047-26-007895-index.html | 0001950047-26-007895 |
| Document: 0001950047-26-007895.txt | 0001950047-26-007895 |
Track record
27 reports on ONC
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers